Date: 12, April, 2019 – 13, April, 2019
Time: 12 Apr 2019 07:45 AM – 13 Apr 2019 09:00 PM (EDT)
Speaker: Dr. Aoy Tomita-Mitchell of Medical College of Wisconsin, Dr. Kip Ludwig of the University of Wisconsin-Madison
Location: Milwaukee School of Engineering, 1047 North Broadway, Milwaukee, Wisconsin, United States 53202, Building: Todd Wehr Conference Center
Event Details & Registration: (URL)
Summary: This special joint meeting of the Great Lakes Biomedical Conference and Rocky Mountain Bioengineering Symposium will bring together researchers delivering technical talks in areas spanning biomedical engineering, from biomechanics to biosignal processing. In addition, a series of keynote presentations and special panel session will be devoted to Translation of Medical Devices: From Idea to Market. Students will compete in poster presentations describing their research and senior design projects. Finally, networking opportunities will allow participants to meet with colleagues, new and old, local and beyond.
The event will feature a special panel session from 5:30-6:30pm on Friday, April 12, entitled Founders Forum: What You Know Now that You Wish You Knew Then, powered by HealthTechMKE.
Moderator: Milton Hwang (Senior Director, Connecture)
Panelists: Scott Bolte (Founder, Trailhead Clinical Strategies, LLC), Lars Olson (Founder, Cortina Medical Devices, LLC), Amanda Baltz (CEO, Spaulding Medical)
Dr. Aoy Tomita-Mitchell
Topic: The Promise of Genetic Research in Congenital Heart Disease in Children
Aoy Tomita-Mitchell, PhD is a Professor in the Department of Surgery, Division of Pediatric Cardiothoracic Surgery at the Medical College of Wisconsin and investigator at the Children’s Research Institute. Her laboratory investigates underlying genetic risk factors of congenital heart disease and is interested in understanding how genetic alterations can impact molecular pathways, resulting in clinical variability. The lab has also conducted pioneering research on circulating cell free DNA. Dr. Tomita-Mitchell has received numerous grants and has numerous publications. She is a co-founder of two biotechnology startup companies, TAI Diagnostics (based in Milwaukee) and Ariosa Diagnostics (San Jose, CA), which was acquired by Roche in January 2015. Aoy graduated from the Massachusetts Institute of Technology where she studied mechanical engineering as an undergraduate and where she also received her PhD in bioengineering in the field of genetic toxicology. She worked in industry and then returned to academia at the Children’s Hospital of Philadelphia as a postdoctoral fellow in pediatric cardiac genetics.
Dr. Kip Ludwig
Topic: Developing an Ecosystem for Parallel Translation of Medical Devices
Associate Professor, Departments of Biomedical Engineering and Neurological Surgery. Neuroengineering Thurst Lead, Grainger Institute for Engineering